Tisdag 22 April | 11:48:59 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-02-26 08:00 Bokslutskommuniké 2025
2025-11-27 08:00 Kvartalsrapport 2025-Q3
2025-08-28 08:00 Kvartalsrapport 2025-Q2
2025-05-30 N/A X-dag ordinarie utdelning SANION 0.00 SEK
2025-05-28 N/A Årsstämma
2025-05-28 08:00 Kvartalsrapport 2025-Q1
2025-02-27 - Bokslutskommuniké 2024
2024-11-28 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-29 - Kvartalsrapport 2024-Q1
2024-05-27 - X-dag ordinarie utdelning SANION 0.00 SEK
2024-05-25 - Årsstämma
2024-02-29 - Bokslutskommuniké 2023
2024-01-16 - Extra Bolagsstämma 2024
2023-11-30 - Kvartalsrapport 2023-Q3
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-25 - Årsstämma
2023-05-25 - Kvartalsrapport 2023-Q1
2023-05-24 - X-dag ordinarie utdelning SANION 0.00 SEK
2023-02-23 - Bokslutskommuniké 2022
2022-11-17 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-08-18 - Extra Bolagsstämma 2022
2022-05-27 - X-dag ordinarie utdelning SANION 0.00 SEK
2022-05-25 - Årsstämma
2022-05-25 - Kvartalsrapport 2022-Q1
2022-02-24 - Bokslutskommuniké 2021
2021-11-18 - Kvartalsrapport 2021-Q3
2021-09-16 - Extra Bolagsstämma 2021
2021-08-26 - Kvartalsrapport 2021-Q2
2021-05-27 - X-dag ordinarie utdelning SANION 0.00 SEK
2021-05-26 - Årsstämma
2021-05-26 - Kvartalsrapport 2021-Q1
2021-03-17 - Bokslutskommuniké 2020
2020-11-30 - Kvartalsrapport 2020-Q3
2020-10-23 - Extra Bolagsstämma 2020
2020-08-27 - Kvartalsrapport 2020-Q2
2020-05-28 - X-dag ordinarie utdelning SANION 0.00 SEK
2020-05-06 - Årsstämma
2020-05-06 - Kvartalsrapport 2020-Q1
2020-02-07 - Extra Bolagsstämma 2019
2020-02-07 - Bokslutskommuniké 2019
2019-11-13 - Kvartalsrapport 2019-Q3
2019-08-21 - Kvartalsrapport 2019-Q2
2019-05-31 - X-dag ordinarie utdelning SANION 0.00 SEK
2019-05-29 - Årsstämma
2019-05-29 - Kvartalsrapport 2019-Q1
2019-02-21 - Bokslutskommuniké 2018
2018-11-14 - Kvartalsrapport 2018-Q3
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-25 - X-dag ordinarie utdelning SANION 0.00 SEK
2018-05-24 - Årsstämma
2018-05-24 - Kvartalsrapport 2018-Q1
2018-02-21 - Bokslutskommuniké 2017
2018-01-19 - Extra Bolagsstämma 2018
2017-11-15 - Kvartalsrapport 2017-Q3
2017-08-23 - Kvartalsrapport 2017-Q2
2017-05-24 - X-dag ordinarie utdelning SANION 0.00 SEK
2017-05-23 - Årsstämma
2017-05-11 - Kvartalsrapport 2017-Q1
2017-02-21 - Bokslutskommuniké 2016
2016-10-13 - Extra Bolagsstämma 2016
2016-05-11 - X-dag ordinarie utdelning SANION 0.00 SEK
2016-05-10 - Årsstämma
2016-05-10 - Kvartalsrapport 2016-Q1
2016-02-19 - Bokslutskommuniké 2015
2015-11-20 - Kvartalsrapport 2015-Q3
2015-09-04 - Extra Bolagsstämma 2015
2015-08-31 - Kvartalsrapport 2015-Q2
2015-05-21 - X-dag ordinarie utdelning SANION 0.00 SEK
2015-05-20 - Årsstämma
2015-05-20 - Kvartalsrapport 2015-Q1
2015-02-20 - Bokslutskommuniké 2014
2014-11-21 - Kvartalsrapport 2014-Q3
2014-08-22 - Kvartalsrapport 2014-Q2

Beskrivning

LandDanmark
ListaSmall Cap Stockholm
SektorHälsovård
IndustriBioteknik
Saniona är verksamt inom bioteknikbranschen och fokuserar på utveckling av innovativa behandlingar för neurologiska och psykiatriska sjukdomar. Bolaget forskar på nya terapier som kan förbättra patientresultat och livskvalitet. Verksamheten är global med en huvudsaklig närvaro i Europa och Nordamerika. Saniona grundades 2011 och har sitt huvudkontor i Glostrup, Danmark.
2023-08-15 13:50:00

Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that Saniona AB (“Saniona” or the “Company”) has now resolved on the set-off new issue to Formue Nord Fokus A/S (“Formue”) that was announced on August 14, 2023.

The board of directors of Saniona has today, pursuant to the authorization granted by the annual general meeting on May 25, 2023, resolved on a directed new issue to Formue of in the aggregate 1,741,301 new shares at a subscription price of SEK 8.50 per share. Formue will pay the subscription price, in the aggregate approximately SEK 14,8 million, through set-off against part of the outstanding loan amount and the prolongation fee payable in connection with the extension of the loan. For further information on the terms of the loan extension, please refer to Saniona’s press release issued on August 14, 2023.

Through the set-off issue, the number of shares in Saniona increases with 1,741,301 from 62,385,677 to 64,126,978 and the share capital increase with SEK 87,065.05 from SEK 3,119,283.85 to SEK 3,206,348.90. The set-off issue entails a dilution of approximately 2.7%.

The subscription price has been determined based on negotiations with Formue and corresponds to a discount of 6.6% compared to the closing price for the Company’s share on Nasdaq Stockholm on August 11, 2023. The board of directors hence considers that the subscription price corresponds to market terms. The reasons for the deviation from the shareholders’ preferential rights are that the new issue is executed due to the amendment to the loan agreement between the Company and Formue. Pursuant to the amendment agreement, the parties agree that the maturity date for the loan shall be postponed and that the Company shall repay a part of the loan, whereby one part shall be repaid in cash and one part through set-off against newly issued shares. In connection with the prolongation, the parties have also agreed that Formue shall receive a prolongation fee that shall be set-off against new issued shares. The board of directors has thoroughly considered various options to raise capital for the partial repayment of the loan and the payment of the prolongation fee. In connection herewith, the board of directors has made the assessment that a rights issue would be significantly more time-consuming, and entail significantly higher costs, mainly due to procurement of a guarantee consortium, and an increased exposure to potential market volatility compared to the directed set-off issue. In light of the above, the board of directors has made the assessment that a directed set-off issue with deviation from the shareholders’ preferential rights is the most favourable alternative for the Company and the Company’s shareholders.